Intracellular localization of proteasomal degradation of a viral antigen

Journal of Cell Biology

Volumn 146, Issue 1, 1999, Pages 113-124

  Antón, Luis C ^a   Schubert, Ulrich ^a,b   Bacík, Igor ^a   Princiotta, Michael F ^a   Wearsch, Pamela A ^a   Gibbs, James ^a   Day, Patricia M ^c   Realini, Claudio ^d   Rechsteiner, Martin C ^d   Bennink, Jack R ^a,e   Yewdell, Jonathan W ^a,e  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF HAMBURG   (Germany)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Antigen presentation; Molecular chaperone; Nuclear proteins proteolysis; Proteasome; Ubiquitin immunology

Indexed keywords

PROTEASOME; VIRUS ANTIGEN; VIRUS NUCLEOPROTEIN;

ANTIGEN DETECTION; ARTICLE; CELLULAR DISTRIBUTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; INFLUENZA VIRUS; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN LOCALIZATION;

ANTIGEN PRESENTATION; ANTIGENS, VIRAL; CANAVANINE; CENTROSOME; CYSTEINE ENDOPEPTIDASES; ENZYME INHIBITORS; FLUORESCENT ANTIBODY TECHNIQUE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LEUPEPTINS; MOLECULAR CHAPERONES; MULTIENZYME COMPLEXES; MUTATION; NUCLEOCAPSID PROTEINS; NUCLEOPROTEINS; ORTHOMYXOVIRIDAE; OSMOLAR CONCENTRATION; PEPTIDE FRAGMENTS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BIOSYNTHESIS; PROTEIN CONFORMATION; PROTEIN FOLDING; SOLUBILITY; TUMOR CELLS, CULTURED; UBIQUITINS; VIRAL CORE PROTEINS;

INFLUENZA VIRUS;

EID: 0033549496     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.146.1.113     Document Type: Article

References (38)

1. Antón, L.C., H.L. Snyder, J.R. Bennink, A. Vinitsky, M. Orlowski, A. Porgador, and J.W. Yewdell. 1998. Dissociation of proteasomal degradation of biosynthesized viral proteins from generation of MHC class I-associated antigenic peptides. J. Immunol. 160:4859-4868.
2. Bercovich, B., I. Stancovski, A. Mayer, N. Blumenfeld, A. Laszlo, A.L. Schwartz, and A. Ciechanover. 1997. Ubiquitin-dependent degradation of certain protein substrates in vitro requires the molecular chaperone Hsc70. J. Biol. Chem. 272:9002-9010.
3. Bogyo, M., M. Gaczynska, and H.L. Ploegh. 1997. Proteasome inhibitors and antigen presentation. Biopolymers. 43:269-280.
4. Chakrabarti, S., K. Brechling, and B. Moss. 1985. Vaccinia virus expression vector: coexpression of β-galactosidase provides visual screening of recombinant virus plaques. Mol. Cell. Biol. 5:3403-3409.
5. Ciechanover, A. 1998. The ubiquitin-proteasome pathway: on protein death and cell life. EMBO (Eur. Mol. Biol. Organ.) J. 17:7151-7160.
6. Cummings, C.J., M.A. Mancini, B. Antalffy, D.B. DeFranco. H.T. Orr, and H.Y. Zoghbi. 1998. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1. Nat. Genet. 19:148-154.
7. Daniel, M.T., M. Koken, O. Romagne, S. Barbey, A. Bazarbachi, M. Stadler, M.C. Guillemin, L. Degos, C. Chomienne, and H. de The. 1993. PML protein expression in hematopoietic and acute promyelocytic leukemia cells. Blood. 82:1858-1867.
8. Desterro, J.M., M.S. Rodriguez, and R.T. Hay. 1998. SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol. Cell. 2:233-239.
9. Dyck, J.A., G.G. Maul, W.H.J. Miller, J.D. Chen, A. Kakizuka, and R.M. Evans. 1994. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell. 76:333-343.
10. Everett, R.D., P. Freemont, H. Saitoh, M. Dasso, A. Orr, M. Kathoria, and J. Parkinson. 1998. The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110- and proteasome-dependent loss of several PML isoforms. J. Virol. 72:6581-6591.
11. Everett, R.D., M. Meredith, and A. Orr. 1999. The ability of herpes simplex virus type 1 immediate-early protein Vmw110 to bind to a ubiquitin-specific protease contributes to its roles in the activation of gene expression and stimulation of virus replication. J. Virol. 73:417-426.
12. Fujimuro, M., H. Sadada, and H. Yokosawa. 1994. Production and characterization of monoclonal antibodies specific to multi-ubiquitin chains of polyubiquitinated proteins. FEBS Lett. 349:173-180.
13. Hendil, K.B., P. Kristensen, and W. Uerkvitz. 1995. Human proteasome analysed with monoclonal antibodies. Biochem. J. 305:245-252.
14. Johnston, J.A., C.L. Ward, and R.R. Kopito. 1998. Aggresomes: a cellular response to misfolded proteins. J. Cell Biol. 143:1883-1898.
15. 4. Nature. 227:680-685.
16. Lee, D.H., and A.L. Goldberg. 1998. Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol. 8:397-403.
17. Mimnaugh, E.G., H.Y. Chen, J.R. Davie, J.E. Celis, and L. Neckers. 1997. Rapid deubiquitination of nucleosomal histones in human tumor cells caused by proteasome inhibitors and stress response inducers: effects on replication, transcription, translation, and the cellular stress response. Biochemistry. 36:14418-14429.
18. Pamer, E., and P. Cresswell. 1998. Mechanisms of MHC class I-restricted antigen processing. Annu. Rev. Immunol. 16:323-358.
19. Parkinson, J., S.P. Lees-Miller, and R.D. Everett. 1999. Herpes simplex virus type 1 immediate-early protein Vmw110 induces the proteasome-dependent degradation of the catalytic subunit of DNA-dependent protein kinase. J. Virol. 73:650-657.
20. Perez, M.K., H.L. Paulson. S.J. Pendse, S.J. Saionz, N.M. Bonini, and R.N. Pittman. 1998. Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation. J. Cell Biol. 143:1457-1470.
21. Porgador, A., J.W. Yewdell, Y. Deng, J.R. Bennink, and R.N. Germain. 1997. Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity. 6:715-726.
22. Realini, C., S.W. Rogers, and M. Rechsteiner. 1994. Proposed roles in protein-protein association and presentation of peptides by MHC class I receptors. FEBS Lett. 348:109-113.
23. Reits, E.A.J., A.M. Benham, B. Plougastel, J. Neefjes, and J. Trowsdale. 1997. Dynamics of proteasome distribution in living cells. EMBO (Eur. Mol. Biol. Organ.) J. 16:6087-6094.
24. Saitoh, H., R.T. Pu, and M. Dasso. 1997. SUMO-1: wrestling with a new ubiquitin-related modifier. Trends Biochem. Sci. 22:374-376.
25. Skinner, P.J., B.T. Koshy, C.J. Cummings, I.A. Klement, K. Helin, A. Servadio, H.Y. Zoghbi, and H.T. Orr. 1997. Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature. 389:971-974.
26. Staufenbiel, M., and W. Deppert. 1984. Preparation of nuclear matrices from cultured cells: subfractionation of nuclei in situ. J. Cell Biol. 98:1886-1894.
27. Sternsdorf, T., T. Grotzinger, K. Jensen, and H. Will. 1997. Nuclear dots: actors on many stages. Immunobiology. 198:307-331.
28. Tevethia, S., M. Tevethia, A. Lewis, V. Reddy, and S. Weissman. 1983. Biology of simian virus 40 (SV40) transplantation antigen (TrAg). IX. Analysis of TrAg in mouse cells synthesizing truncated SV40 large T antigen. Virology. 128:319-330.
29. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA. 76:4350-4354.
30. Townsend, A., J. Bastin, K. Gould, G. Brownlee, M. Andrew, B. Coupar, D. Boyle, S. Chan, and G. Smith. 1988. Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen. J. Exp. Med. 168:1211-1224.
31. Wang, P., P. Palese, and R.E. O'Neill. 1997. The NPI-1/NPI-3 (karyopherin α) binding site on the influenza A virus nucleoprotein NP is a nonconventional nuclear localization signal. J. Virol. 71:1850-1856.
32. Weis, K., S. Rambaud, C. Lavau, J. Jansen, T. Carvalho, M. Carmo-Fonseca, A. Lamond, and A. Dejean. 1994. Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells. Cell. 76:345-356.
33. Wojcik, C., D. Schroeter, S. Wilk, J. Lamprecht, and N. Paweletz. 1996. Ubiquitin-mediated proteolysis centers in HeLa cells: indication from studies of an inhibitor of the chymotrypsin-like activity of the proteasome. Eur. J. Cell Biol. 71:311-318.
34. Yewdell, J.W., E. Frank, and W. Gerhard. 1981. Expression of influenza A virus internal antigens on the surface of infected P815 cells. J. Immunol 126: 1814-1819.
35. York, I., and K.L. Rock. 1996. Antigen processing and presentation by the class I major histocompatibility complex. Annu. Rev. Immunol. 14:369-396.
36. Yoshida, H., K. Kitamura, K. Tanaka, S. Omura, T. Miyazaki, T. Hachiya, R. Ohno, and T. Naoe. 1996. Accelerated degradation of PML-retinoic acid receptor alpha (PML-RARA) oncoprotein by all-trans-retinoic acid in acute promyelocytic leukemia: possible role of the proteasome pathway. Cancer Res. 56:2945-2948.
37. Zheng, P., Y. Guo, Q. Niu, D.E. Levy, J.A. Dyck, S. Lu, L.A. Sheiman, and Y. Liu. 1998. Proto-oncogene PML controls genes devoted to MHC class I antigen presentation. Nature. 396:373-376.
38. Zhu, J., M.H. Koken, F. Quignon, M.K. Chelbi-Alix, L. Degos, Z.Y. Wang, Z. Chen, and H. de The. 1997. Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia. Proc. Natl. Acad. Sci. USA. 94:3978-3983.